News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
241,863 Results
Type
Article (7195)
Company Profile (32)
Press Release (234636)
Section
Business (88252)
Career Advice (547)
Deals (15623)
Drug Delivery (12)
Drug Development (21048)
Employer Resources (32)
FDA (4007)
Job Trends (4362)
News (129190)
Policy (8278)
Tag
Academia (612)
Alliances (17193)
Alzheimer's disease (246)
Approvals (4001)
Artificial intelligence (27)
Bankruptcy (105)
Best Places to Work (3182)
Biotechnology (30)
Cancer (268)
Career advice (466)
Cell therapy (67)
Clinical research (17110)
Collaboration (109)
Compensation (68)
COVID-19 (499)
C-suite (48)
Data (315)
Diabetes (25)
Diagnostics (2202)
Earnings (40619)
Employer resources (32)
Events (39220)
Executive appointments (144)
FDA (4127)
Funding (113)
Gene therapy (28)
GLP-1 (109)
Government (649)
Healthcare (5507)
Infectious disease (517)
Inflammatory bowel disease (24)
Interviews (62)
IPO (7939)
Job creations (1264)
Job search strategy (432)
Layoffs (105)
Legal (2423)
Lung cancer (27)
Manufacturing (36)
Medical device (4181)
Medtech (4182)
Mergers & acquisitions (7721)
Metabolic disorders (79)
Neuroscience (296)
NextGen Class of 2024 (1878)
Non-profit (1036)
Northern California (553)
Obesity (40)
Opinion (36)
People (26495)
Phase I (5192)
Phase II (7510)
Phase III (5804)
Pipeline (267)
Postmarket research (656)
Preclinical (2124)
Press Release (70)
Radiopharmaceuticals (104)
Rare diseases (43)
Real estate (2141)
Regulatory (5459)
Research institute (655)
Resumes & cover letters (77)
Southern California (421)
Startups (1217)
United States (4570)
Vaccines (50)
Date
Today (14)
Last 7 days (181)
Last 30 days (1314)
Last 365 days (12039)
2024 (11152)
2023 (14238)
2022 (20045)
2021 (21270)
2020 (20047)
2019 (14690)
2018 (11375)
2017 (11323)
2016 (10427)
2015 (13513)
2014 (10676)
2013 (8692)
2012 (9103)
2011 (9693)
2010 (9404)
Location
Africa (218)
Arizona (50)
Asia (12438)
Australia (1818)
California (1133)
Canada (486)
China (36)
Colorado (45)
Connecticut (59)
Europe (26500)
Florida (146)
Georgia (43)
Illinois (82)
Indiana (36)
Japan (31)
Kansas (26)
Maine (34)
Maryland (148)
Massachusetts (955)
Michigan (65)
Minnesota (114)
New Jersey (368)
New York (336)
North Carolina (257)
Northern California (553)
Ohio (45)
Pennsylvania (248)
South America (316)
Southern California (421)
Texas (143)
Utah (31)
Virginia (26)
Washington State (104)
241,863 Results for "optiscan biomedical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Optiscan Signs Know-How Agreement with Mayo Clinic
Optiscan Imaging Limited is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for use in robotic surgery.
May 13, 2024
·
5 min read
Press Releases
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 12, 2024
·
12 min read
Business
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 9, 2024
·
8 min read
Press Releases
Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024
November 1, 2024
·
1 min read
Press Releases
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
October 4, 2024
·
20 min read
Press Releases
Lifecore Biomedical Hosts Virtual Investor Day
November 22, 2024
·
1 min read
BioMidwest
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.
June 12, 2024
·
7 min read
Business
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today reported financial results for the fourth quarter and year ended December 31, 2023, and provided a corporate update.
March 12, 2024
·
11 min read
Business
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 12, 2024
·
11 min read
Press Releases
Lifecore Biomedical to Present at Stephens Annual Investment Conference
November 13, 2024
·
1 min read
1 of 24,187
Next
